Bone-specific delivery and sustained release of diclofenac, a non-steroidal anti-inflammatory drug, via bisphosphonic prodrug based on the Osteotropic Drug Delivery System (ODDS)

Authors: Hirabayashi H.; Takahashi T.; Fujisaki J.; Masunaga T.; Sato S.; Hiroi J.; Tokunaga Y.; Kimura S.; Hata T.

Source: Journal of Controlled Release, Volume 70, Number 1, 29 January 2001 , pp. 183-191(9)

Publisher: Elsevier

Keywords: Osteotropic drug delivery system; Biphosphonate; Prodrug; Diclofenac; Rat adjuvant

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0168-3659(00)00355-2

Affiliations: 1: aBiopharmaceutical and Pharmacokinetic Research Laboratories, Fujisawa Pharmaceutical Company, 1-6, Kashima 2-chome, Yodogawa-ku, 532-8514, Osaka, Japan

Publication date: 2001-01-29

• In this: publication
• By this: publisher
• In this Subject: Chemical Engineering ,  Pharmacology
• By this author: Hirabayashi H. ;  Takahashi T. ;  Fujisaki J. ;  Masunaga T. ;  Sato S. ;  Hiroi J. ;  Tokunaga Y. ;  Kimura S. ;  Hata T.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers